All three PDGFRB inhibitors at 10 μM (p < 0.005) and 0.05 μM (p < 0.005) concentrations significantly decreased 4-OH Pro levels in ARPKD organoids (Fig. 7f, g). This evidence concerns the gene PDGFRB and autosomal recessive polycystic kidney disease.